(EMAILWIRE.COM<\/a>, April 17, 2025 ) InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the “Global AI ML and Computational Tools in RNA Research and Therapeutics Market<\/a> Size, Share & Trends Analysis Report By Technologies and Processes (RNA Design and Sequence Optimization, RNA Delivery Systems, RNA Sequencing and Data Analysis, Target Identification and Validation, Preclinical and Clinical Development Tools, Hardware and Infrastructure Support), Product (Vaccines, Drugs), Type (mRNA Therapeutics, RNA Interference (RNAi) Therapeutics, Antisense Oligonucleotide (ASO) Therapeutics, Other Therapeutics), End-User (Pharmaceutical and Biotech Companies, Academic and Research Institutions, Contract Research Organizations (CROs), Healthcare Providers (Emerging))- Market Outlook And Industry Analysis 2034″<\/p>\n Global AI\/ML and Computational Tools in RNA Research and Therapeutics Market Size is predicted to develop at an 26.8% CAGR during the forecast period for 2025-2034.<\/p>\n Global AI\/ML and Computational Tools in RNA Research and Therapeutics Market 2025-2034 full Research Repot latest version is now available.<\/p>\n Get Free Access to Demo Report, Excel Pivot and ToC: https:\/\/www.insightaceanalytic.com\/request-sample\/2974<\/a><\/p>\n Artificial Intelligence (AI), Machine Learning (ML), and computational tools are reshaping RNA research and therapeutics by enabling scientists to better understand the complexities of RNA biology and speed up the development of RNA-driven treatments. RNA plays diverse roles in cellular function, and AI\/ML technologies are unlocking new insights into its structure, function, and interactions. <\/p>\n These tools analyze large datasets to predict RNA structures, identify disease-relevant targets, optimize sequences, and design therapeutics such as mRNA vaccines, siRNAs, and ASOs. Computational platforms\u0097including algorithms, software, databases\u0097automate and streamline data analysis, drug design, and therapeutic optimization. <\/p>\n Applications span RNA structure prediction, target identification using graph-based models like Random Walk Diffusions, and drug development via platforms like TREAT. Additionally, AI\/ML enhances RNA sequencing analysis and supports precision medicine through biomarker discovery and personalized therapy design. By addressing challenges like data complexity and limited structural information, these technologies are driving innovation in RNA-targeted therapies across a broad spectrum of diseases.<\/p>\n List of Prominent Players in the AI\/ML and Computational Tools in RNA Research and Therapeutics Market:<\/p>\n \u0095\tDeep Genomics AI\/ML and Computational Tools in RNA Research and Therapeutics Market Report Scope: Expert Knowledge, Just a Click Away: https:\/\/calendly.com\/insightaceanalytic\/30min?month=2025-04<\/a><\/p>\n Market Dynamics: As RNA drugs continue to widen their scope towards treating complex diseases, enhanced AI algorithms and co-option with orthogonal technologies are upgrading research potential. Increased investments and partnerships across industry and academia continue to fuel further innovation in this fast-paced discipline.<\/p>\n Challenges: Regional Trends: The region enjoys a supportive regulatory environment, with the FDA embracing RNA-based treatments and providing accelerated pathways such as Fast Track and Breakthrough Therapy designations. Also, North America’s advanced R&D infrastructure\u0097consisting of leading-edge labs, state-of-the-art sequencing technologies, and high-performance computing capabilities\u0097is yet another factor that facilitates the effective application of AI\/ML in RNA research and drug development.<\/p>\n Unlock Your GTM Strategy: https:\/\/www.insightaceanalytic.com\/customisation\/2974<\/a><\/p>\n Recent Developments: Segmentation of Trusted Platform Module Market- View Overview Report: https:\/\/www.insightaceanalytic.com\/report\/aiml-and-computational-tools-in-rna-research-and-therapeutics-market\/2974<\/a><\/p>\n Why should buy this report: About Us: Contact US:![](\"http:\/\/www.emailwire.com\/files\/pr_images\/mid_thumbs\/1_1744804281_1148543.jpg\" "\\"Segmentation")
Segmentation of AI\/ML and Computational Tools in RNA Research and Therapeutics Market<\/span><\/a><\/p>\n<\/div>\n
\n\u0095\tInsilico Medicine
\n\u0095\tAtomwise
\n\u0095\tSchr\u00f6dinger
\n\u0095\tGenerate Biomedicines
\n\u0095\te-therapeutics
\n\u0095\tNVIDIA
\n\u0095\tIllumina
\n\u0095\tRelation Therapeutics
\n\u0095\tBenevolentAI
\n\u0095\tFluence Technologies
\n\u0095\tSatija Lab<\/p>\n
\nReport Attribute\tSpecifications
\nMarket Size Value In 2024\tUSD XX Mn
\nMarket Size Value In 2034\tUSD XX Mn
\nGrowth rate CAGR\tCAGR of XX% from 2025 to 2034
\nQuantitative units\tRepresentation of revenue in US$ Mn, and CAGR from 2025 to 2034
\nHistoric Year\t2021 to 2024
\nForecast Year\t2025-2034
\nReport coverage\tThe forecast of revenue, the position of the company, the competitive market statistics, growth prospects, and trends
\nSegments covered\tBy Technologies and Processes, Product, Type, End-User
\nRegional scope\tNorth America; Europe; Asia Pacific; Latin America; Middle East & Africa
\nCountry scope\tU.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; Southeast Asia<\/p>\n
\nDrivers-
\nThe use of AI\/ML and computational technologies in RNA therapeutics and research is driven by developments in RNA technologies, the explosion of sequencing information, and the imperative for expedited, inexpensive drug discovery. They allow for rapid target identification, improve RNA therapeutics such as mRNA vaccines and siRNAs, and facilitate personalized medicine using patient-specific data analysis. <\/p>\n
\nDespite their promise and inconsistent experimental data hinder model training and accuracy. The intrinsic complexity of RNA biology, with its immense structural and functional diversity, makes it challenging to trace sequence-function relationships and prevent error propagation in multi-step analysis. Furthermore, modeling successful delivery of RNA therapeutics continues to be challenging owing to issues such as molecular instability, bulkiness, and barriers to cellular uptake.<\/p>\n
\nNorth America is at the forefront of AI\/ML integration in RNA therapeutics, fueled by the presence of large pharma players such as Pfizer and Moderna, biotech pioneers like Alnylam and Ionis Pharmaceuticals, and an increasing number of AI-driven startups. <\/p>\n
\n\u0095\tIn July 2024, Schr\u00f6dinger launched an initiative to enhance early toxicology prediction in drug discovery using its physics-based platform and NVIDIA\u0092s AI, aiming to reduce safety-related failures and speed up development\u0097aligning with the FDA\u0092s Predictive Toxicology Roadmap.
\n\u0095\tIn Sep 2023, Deep Genomics unveiled its AI foundation model, BigRNA, through a new manuscript highlighting its ability to predict tissue-specific RNA regulation, protein\/microRNA binding sites, and therapeutic effects. Unlike task-specific tools, BigRNA enables broad biological discovery and identification of novel RNA therapeutics, marking a significant advance in AI-driven drug development.<\/p>\n
\nBy Technologies and Processes:
\n\u0095\tRNA Design and Sequence Optimization
\n\u0095\tRNA Delivery Systems
\n\u0095\tRNA Sequencing and Data Analysis
\n\u0095\tTarget Identification and Validation
\n\u0095\tPreclinical and Clinical Development Tools
\n\u0095\tHardware and Infrastructure Support
\nBy Product:
\n\u0095\tVaccines
\n\u0095\tDrugs
\nBy Type:
\n\u0095\tmRNA Therapeutics
\n\u0095\tRNA Interference (RNAi) Therapeutics
\n\u0095\tAntisense Oligonucleotide (ASO) Therapeutics
\n\u0095\tOther Therapeutics
\nBy End-User:
\n\u0095\tPharmaceutical and Biotech Companies
\n\u0095\tAcademic and Research Institutions
\n\u0095\tContract Research Organizations (CROs)
\n\u0095\tHealthcare Providers (Emerging)
\nBy Region-
\nNorth America-
\n\u0095\tThe US
\n\u0095\tCanada
\nEurope-
\n\u0095\tGermany
\n\u0095\tThe UK
\n\u0095\tFrance
\n\u0095\tItaly
\n\u0095\tSpain
\n\u0095\tRest of Europe
\nAsia-Pacific-
\n\u0095\tChina
\n\u0095\tJapan
\n\u0095\tIndia
\n\u0095\tSouth Korea
\n\u0095\tSouth East Asia
\n\u0095\tRest of Asia Pacific
\nLatin America-
\n\u0095\tBrazil
\n\u0095\tArgentina
\n\u0095\tMexico
\n\u0095\tRest of Latin America
\n Middle East & Africa-
\n\u0095\tGCC Countries
\n\u0095\tSouth Africa
\n\u0095\tRest of Middle East and Africa<\/p>\n
\n\uf0d8\tTo receive a comprehensive analysis of the prospects for global AI\/ML and Computational Tools in RNA Research and Therapeutics market
\n\uf0d8\tTo receive industry overview and future trends of global AI\/ML and Computational Tools in RNA Research and Therapeutics market
\n\uf0d8\tTo analyze the AI\/ML and Computational Tools in RNA Research and Therapeutics market drivers and challenges
\n\uf0d8\tTo get information on the AI\/ML and Computational Tools in RNA Research and Therapeutics market size value (US$ Mn) forecast till 2034
\n\uf0d8\tMajor Investments, Mergers & Acquisition in global AI\/ML and Computational Tools in RNA Research and Therapeutics industry<\/p>\n
\nInsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.<\/p>\n
\nInsightAce Analytic Pvt. Ltd.
\nTel.: +1 718 593 4405
\nEmail: info@insightaceanalytic.com
\nSite Visit: www.insightaceanalytic.com<\/a>
\nFollow Us on LinkedIn @ bit.ly\/2tBXsgS
\nFollow Us On Facebook @ bit.ly\/2H9jnDZ\n <\/div>\n